Role of the ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein Arc

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 22, 2013, Pages 8888-8893

  Kühnle, Simone ^a   Mothes, Benedikt ^a,b   Matentzoglu, Konstantin ^a,c   Scheffner, Martin ^a,d  

^a Department of Biology ^*  (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Trenzyme GmbH   (Germany)

^d UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN; ESTRADIOL; UBIQUITIN LIGASE E6 ASSOCIATED PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSCRIPTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; UBIQUITINATION;

CELL LINE; CYTOSKELETAL PROTEINS; DNA PRIMERS; ESCHERICHIA COLI; ESTRADIOL; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUCIFERASES; NERVE TISSUE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; SYNAPSES; TRANSFECTION; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

MUS;

EID: 84878464396     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1302792110     Document Type: Article

References (61)

1. Kerscher O, Felberbaum R, Hochstrasser M (2006) Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu Rev Cell Dev Biol 22:159-180.
2. Varshavsky A (2012) The ubiquitin system, an immense realm. Annu Rev Biochem 81:167-176.
3. Schwartz AL, Ciechanover A (2009) Targeting proteins for destruction by the ubiquitin system: Implications for human pathobiology. Annu Rev Pharmacol Toxicol 49: 73-96.
4. Edelmann MJ, Nicholson B, Kessler BM (2011) Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases. Expert Rev Mol Med 13:e35.
5. Nicholls RD, Knepper JL (2001) Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu Rev Genomics Hum Genet 2:153-175.
6. Yamamoto Y, Huibregtse JM, Howley PM (1997) The human E6-AP gene (UBE3A) encodes three potential protein isoforms generated by differential splicing. Genomics 41(2):263-266.
7. Huibregtse JM, Scheffner M, Howley PM (1991) A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 10(13):4129-4135.
8. Huibregtse JM, Scheffner M, Howley PM (1993) Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol Cell Biol 13(2):775-784.
9. Beaudenon S, Huibregtse JM (2008) HPV E6, E6AP and cervical cancer. BMC Biochem 9(Suppl 1):S4.
10. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75(3):495-505.
11. Clayton-Smith J, Laan L (2003) Angelman syndrome: A review of the clinical and genetic aspects. J Med Genet 40(2):87-95.
12. Dagli A, Buiting K, Williams CA (2012) Molecular and clinical aspects of Angelman syndrome. Mol Syndromol 2(3-5):100-112.
13. Kishino T, Lalande M, Wagstaff J (1997) UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet 15(1):70-73.
14. Matsuura T, et al. (1997) De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet 15(1):74-77.
15. Glessner JT, et al. (2009) Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459(7246):569-573.
16. Hogart A, Wu D, LaSalle JM, Schanen NC (2010) The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13. Neurobiol Dis 38(2):181-191.
17. Smith SE, et al. (2011) Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice. Sci Transl Med 3(103):103ra197.
18. Metzger MB, Hristova VA, Weissman AM (2012) HECT and RING finger families of E3 ubiquitin ligases at a glance. J Cell Sci 125(Pt 3):531-537.
19. Kumar S, Talis AL, Howley PM (1999) Identification of HHR23A as a substrate for E6-associated protein-mediated ubiquitination. J Biol Chem 274(26):18785-18792.
20. Mulherkar SA, Sharma J, Jana NR (2009) The ubiquitin ligase E6-AP promotes degradation of alpha-synuclein. J Neurochem 110(6):1955-1964.
21. Louria-Hayon I, et al. (2009) E6AP promotes the degradation of the PML tumor suppressor. Cell Death Differ 16(8):1156-1166.
22. Mani A, et al. (2006) E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells. Cancer Res 66(17):8680-8686.
23. Zaaroor-Regev D, et al. (2010) Regulation of the polycomb protein Ring1B by selfubiquitination or by E6-AP may have implications to the pathogenesis of Angelman syndrome. Proc Natl Acad Sci USA 107(15):6788-6793.
24. Jiang YH, et al. (1998) Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 21(4):799-811.
25. Miura K, et al. (2002) Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice. Neurobiol Dis 9(2):149-159.
26. Greer PL, et al. (2010) The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell 140(5):704-716.
27. Kamionka M, Feigon J (2004) Structure of the XPC binding domain of hHR23A reveals hydrophobic patches for protein interaction. Protein Sci 13(9):2370-2377.
28. Dantuma NP, Heinen C, Hoogstraten D (2009) The ubiquitin receptor Rad23: At the crossroads of nucleotide excision repair and proteasomal degradation. DNA Repair (Amst) 8(4):449-460.
29. Dikic I, Wakatsuki S, Walters KJ (2009) Ubiquitin-binding domains-from structures to functions. Nat Rev Mol Cell Biol 10(10):659-671.
30. Glockzin S, Ogi FX, Hengstermann A, Scheffner M, Blattner C (2003) Involvement of the DNA repair protein hHR23 in p53 degradation. Mol Cell Biol 23(24):8960-8969.
31. Beer-Romero P, Glass S, Rolfe M (1997) Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells. Oncogene 14(5):595-602.
32. Hengstermann A, et al. (2005) Growth suppression induced by downregulation of E6-AP expression in human papillomavirus-positive cancer cell lines depends on p53. J Virol 79(14):9296-9300.
33. Kim Y, Cairns MJ, Marouga R, Sun LQ (2003) E6AP gene suppression and characterization with in vitro selected hammerhead ribozymes. Cancer Gene Ther 10(9): 707-716.
34. Talis AL, Huibregtse JM, Howley PM (1998) The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J Biol Chem 273(11):6439-6445.
35. Hengstermann A, Whitaker NJ, Zimmer D, Zentgraf H, Scheffner M (1998) Characterization of sequence elements involved in p53 stability regulation reveals cell type dependence for p53 degradation. Oncogene 17(22):2933-2941.
36. Bachmair A, Finley D, Varshavsky A (1986) In vivo half-life of a protein is a function of its amino-terminal residue. Science 234(4773):179-186.
37. Varshavsky A (2005) Ubiquitin fusion technique and related methods. Methods Enzymol 399:777-799.
38. Matentzoglu K, Scheffner M (2009) Ubiquitin-fusion protein system: A powerful tool for ectopic protein expression in mammalian cells. Biotechniques 46(1):21-22, 24, 26 passim.
39. Kuhnle S, et al. (2011) Physical and functional interaction of the HECT ubiquitinprotein ligases E6AP and HERC2. J Biol Chem 286(22):19410-19416.
40. Salvat C, Wang G, Dastur A, Lyon N, Huibregtse JM (2004) The-4 phenylalanine is required for substrate ubiquitination catalyzed by HECT ubiquitin ligases. J Biol Chem 279(18):18935-18943.
41. Nawaz Z, et al. (1999) The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol Cell Biol 19(2): 1182-1189.
42. Li L, Li Z, Howley PM, Sacks DB (2006) E6AP and calmodulin reciprocally regulate estrogen receptor stability. J Biol Chem 281(4):1978-1985.
43. Ramamoorthy S, Dhananjayan SC, Demayo FJ, Nawaz Z (2010) Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development. Mol Endocrinol 24(11):2099-2113.
44. Chamniansawat S, Chongthammakun S (2009) Estrogen stimulates activity-regulated cytoskeleton associated protein (Arc) expression via the MAPK-and PI-3K-dependent pathways in SH-SY5Y cells. Neurosci Lett 452(2):130-135.
45. Kuballa P, Matentzoglu K, ScheffnerM(2007) The role of the ubiquitin ligase E6-AP in human papillomavirus E6-mediated degradation of PDZ domain-containing proteins. J Biol Chem 282(1):65-71.
46. Fang P, et al. (1999) The spectrum of mutations in UBE3A causing Angelman syndrome. Hum Mol Genet 8(1):129-135.
47. Cooper EM, Hudson AW, Amos J, Wagstaff J, Howley PM (2004) Biochemical analysis of Angelman syndrome-associated mutations in the E3 ubiquitin ligase E6-associated protein. J Biol Chem 279(39):41208-41217.
48. Bramham CR, Worley PF, Moore MJ, Guzowski JF (2008) The immediate early gene arc/arg3.1: Regulation, mechanisms, and function. J Neurosci 28(46):11760-11767.
49. Yashiro K, et al. (2009) Ube3a is required for experience-dependent maturation of the neocortex. Nat Neurosci 12(6):777-783.
50. Soulé J, et al. (2012) Balancing Arc synthesis, mRNA decay, and proteasomal degradation: Maximal protein expression triggered by rapid eye movement sleep-like bursts of muscarinic cholinergic receptor stimulation. J Biol Chem 287(26): 22354-22366.
51. Teber I, Köhling R, Speckmann EJ, Barnekow A, Kremerskothen J (2004) Muscarinic acetylcholine receptor stimulation induces expression of the activity-regulated cytoskeleton-associated gene (ARC). Brain Res Mol Brain Res 121(1-2):131-136.
52. Casadesus G (2010) Special issue on estrogen actions in the brain. Biochim Biophys Acta 1800(10):1029.
53. Córdoba Montoya DA, Carrer HF (1997) Estrogen facilitates induction of long term potentiation in the hippocampus of awake rats. Brain Res 778(2):430-438.
54. Kim HJ, Casadesus G (2010) Estrogen-mediated effects on cognition and synaptic plasticity: What do estrogen receptor knockout models tell us? Biochim Biophys Acta 1800(10):1090-1093.
55. Rissman EF, Heck AL, Leonard JE, Shupnik MA, Gustafsson JA (2002) Disruption of estrogen receptor beta gene impairs spatial learning in female mice. Proc Natl Acad Sci USA 99(6):3996-4001.
56. Srivastava DP, et al. (2011) Rapid estrogen signaling in the brain: Implications for the fine-tuning of neuronal circuitry. J Neurosci 31(45):16056-16063.
57. Catoe HW, Nawaz Z (2011) E6-AP facilitates efficient transcription at estrogen responsive promoters through recruitment of chromatin modifiers. Steroids 76(9): 897-902.
58. Carroll JS, et al. (2006) Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38(11):1289-1297.
59. Johnsen SA, et al. (2009) Regulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancer. Cancer Res 69(1):128-136.
60. Winer J, Jung CK, Shackel I, Williams PM (1999) Development and validation of realtime quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270(1):41-49.
61. Schmittgen TD, et al. (2000) Quantitative reverse transcription- polymerase chain reaction to study mRNA decay: Comparison of endpoint and real-time methods. Anal Biochem 285(2):194-204.